Trials / Unknown
UnknownNCT03793634
Evaluation of Topical Chamomile Versus Topical Triamcinolone Acetonide in Management of Oral Lichen Planus
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 37 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 30 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Using of herbal medications as topical chamomile which has antioxidant, anti-inflammatory and anticarcinogenesis effect with little side effects is the aim for the future treatment of OLP.
Detailed description
Oral lichen planus (OLP) is a chronic inflammatory T cell mediated autoimmune disease that affects skin and any mucous membrane particularly oral mucosa.The patient complains of burning sensation, pain; interference with eating, swallowing and speech leading to worsening of quality of life.Oxidative stress plays a role in pathomechanism of OLP disease. Enzymatic and non- enzymatic anti-oxidants act as a physiological guard against reactive oxygen species (ROS) and cytokine-mediated toxicity.Herbal treatment is the aim of the future therapy.Chamomile has anti-oxidant , anti-inflammatory effect and accelerate healing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | topical chamomile | herbal medication which has antioxidant, anti-inflammatory and anticarcinogenesis effect |
Timeline
- Start date
- 2019-01-15
- Primary completion
- 2019-12-01
- Completion
- 2020-03-01
- First posted
- 2019-01-04
- Last updated
- 2019-01-04
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03793634. Inclusion in this directory is not an endorsement.